Effects of pharmacist care on hospitalizations in heart failure across outpatient and inpatient settings: A systematic review and meta‐analysis
Auswirkungen pharmazeutischer Versorgung auf Hospitalisierungen bei Herzinsuffizienz in ambulanten und stationären Settings: systematische Übersicht und Metaanalyse
British Journal of Clinical Pharmacology · 2025-11 · 91 (11) · 3021-3030
DOI: 10.1002/bcp.70261 ↗Auf einen Blick
Elf Studien zeigen: Pharmazeutische Interventionen waren mit weniger Hospitalisierungen bei Herzinsuffizienz verbunden. Auch all-cause Hospitalisierungen nahmen gegenüber der Standardversorgung ab.
Fragestellung
Welche Wirkung haben pharmazeutische Interventionen auf Hospitalisierungen und Mortalität bei Patient:innen mit Herzinsuffizienz?
Methode
Systematische Übersicht und Metaanalyse randomisierter kontrollierter Studien; Suche in PUBMED und EMBASE bis November 2024; Bewertung mit Cochrane Risk-of-Bias-Tool.
Ergebnisse
11 Studien mit 3576 Patient:innen. All-cause Hospitalisierungen: OR 0,67 (95 %-KI 0,49–0,92; 3472 Patient:innen, 927 Ereignisse). HF-Hospitalisierungen: OR 0,64 (95 %-KI 0,48–0,87; 3442 Patient:innen, 504 Ereignisse).
Einschränkungen
Moderate Heterogenität in beiden Analysen.
Schlussfolgerung der Autor:innen
Nach Ansicht der Autor:innen reduzierten pharmazeutische Interventionen in stationären und ambulanten Settings all-cause und HF-Hospitalisierungen signifikant.
Kernaussagen
- All-cause Hospitalisierungen seltener unter pharmazeutischen Interventionen
- HF-Hospitalisierungen ebenfalls reduziert
- Subgruppenanalyse: größere Wirkung ambulant und bei längeren Interventionen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Metaanalyse in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 21.08.2025. Verfasst von Lorenz Van der Linden und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Pharmacy Department, University Hospitals Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Heart Failure, Hospitalization, Pharmacists, Pharmacy Service, Hospital. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Clinical Research Fund of the University Hospitals Leuven.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
Heart failure (HF) is major cause of unplanned (re)hospitalizations, especially in high‐risk patients such as those recently discharged or those with worsening HF. Hospital‐affiliated or clinic‐based pharmacists, though underutilized, may help reduce this burden. This systematic review and meta‐analysis assessed their impact on all‐cause and HF hospitalizations.
Methods
A systematic literature search using PUBMED and EMBASE and conducted according to PRISMA guidelines identified randomized controlled trials published up to November 2024. Eligible studies evaluated the effects of pharmacy interventions on hospitalizations and mortality among patients with HF. Studies with community pharmacy‐ or home‐based interventions were excluded. Study quality was appraised using the Cochrane risk‐of‐bias tool. Random‐effects models were applied to derive odds ratios (OR), with heterogeneity assessed using the I 2 statistic and Cochrane's Q test.
Results
Eleven studies were included, involving 3576 patients and a variety of pharmacist interventions. Pharmacists significantly reduced the odds of all‐cause hospitalizations compared to usual care (3472 patients, 927 events; OR 0.67, 95% confidence interval [CI]: 0.49–0.92, P = 0.0119). For HF hospitalizations (3442 patients, 504 events), similar results were retrieved (OR 0.64, 95% CI: 0.48–0.87, P = 0.0038). Heterogeneity was moderate for both analyses. Sensitivity analyses supported the robustness of these two analyses. Subgroup analyses indicated greater effectiveness in outpatient settings and when extended interventions were provided.
Conclusions
Across inpatient and outpatient settings, pharmacist interventions in HF significantly reduced all‐cause as well as HF hospitalizations. Our findings highlight the importance of integrating pharmacists into multidisciplinary teams to improve HF management for in‐ and outpatients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital Pharmacy Department, University Hospitals Leuven, Leuven, Belgium.
- Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
- Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, Kentucky, USA.
- Department of Pharmacy, NHS Greater Glasgow & Clyde, Glasgow, Scotland, UK.
- Department of Anaesthetics, Pain Medicine and Critical Care, Imperial College, London, UK.
- Cardiology and Cardiac Intensive Care, Heart Center, OLV Hospital Aalst, Aalst, Belgium.
ORCID-Profile: Lorenz Van der Linden
Förderung
- Clinical Research Fund of the University Hospitals Leuven
Zitieren
APA
Van der Linden, L., Beavers, C., Forsyth, P., Vandenbriele, C., Tsuyuki, R. T., Karapinar-Carkıt, F., & Van Aelst, L. (2025). Effects of pharmacist care on hospitalizations in heart failure across outpatient and inpatient settings: A systematic review and meta‐analysis. British Journal of Clinical Pharmacology, 91(11), 3021-3030. https://doi.org/10.1002/bcp.70261
Vancouver
Van der Linden L, Beavers C, Forsyth P, Vandenbriele C, Tsuyuki RT, Karapinar-Carkıt F, et al. Effects of pharmacist care on hospitalizations in heart failure across outpatient and inpatient settings: A systematic review and meta‐analysis. British Journal of Clinical Pharmacology. 2025;91(11):3021-3030. doi:10.1002/bcp.70261
BibTeX
@article{VanderLinden2025,
author = {Van der Linden, Lorenz and Beavers, Craig and Forsyth, Paul and Vandenbriele, Christophe and Tsuyuki, Ross T and Karapinar-Carkıt, Fatma and Van Aelst, Lucas},
title = {Effects of pharmacist care on hospitalizations in heart failure across outpatient and inpatient settings: A systematic review and meta‐analysis},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
volume = {91},
number = {11},
pages = {3021--3030},
doi = {10.1002/bcp.70261}
}
EUVIMED